Clioquinol and vitamin B12 (cobalamin) synergistically rescue the lead-induced impairments of synaptic plasticity in hippocampal dentate gyrus area of the anesthetized rats in vivo

Neuroscience

Volumn 147, Issue 3, 2007, Pages 853-864

  Chen, W H ^a   Wang, M ^a   Yu, S S ^a   Su, L ^a   Zhu, D M ^a   She, J Q ^a   Cao, X J ^a   Ruan, D Y ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

clioquinol; dentate gyrus; hippocampus; lead; rat

Indexed keywords

CLIOQUINOL; CYANOCOBALAMIN; LEAD;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DRUG MECHANISM; DRUG POTENTIATION; HIPPOCAMPUS; IN VIVO STUDY; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANESTHESIA; ANIMALS; CLIOQUINOL; DENTATE GYRUS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; LEAD POISONING; LONG-TERM POTENTIATION; NEURONAL PLASTICITY; RATS; RATS, WISTAR; SYNAPSES; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 34250793837     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.04.042     Document Type: Article

References (39)

1. Adonaylo V.N., and Oteiza P.I. Lead intoxication: antioxidant defenses and oxidative damage in rat brain. Toxicology 135 (1999) 77-85
2. Altmann L., Weinsberg F., Sveinsson K., Lilienthal H., Wiegand H., and Winneke G. Impairment of long-term potentiation and learning following chronic lead-exposure. Toxicol Lett 66 (1993) 105-112
3. Arbiser J.L., Kraeft S.K., van Leeuwen R., Hurwitz S.J., Selig M., Dickersin G.R., Flint A., Byers H.R., and Chen L.B. Clioquinol-zinc chelate: A candidate causative agent of subacute myelo-optic neuropathy. Mol Med 4 (1998) 665-670
4. Banks E.C., Ferretti L.E., and Shucard D.W. Effects of low level lead exposure on cognitive function in children: A review of behavioral, neuropsychological and biological evidence. Neurotoxicology 18 (1997) 237-281
5. Bellinger D., Sloman J., Leviton A., Rabinowitz M., Needleman H.L., and Waternaux C. Low-level lead-exposure and children's cognitive function in the preschool years. Pediatrics 87 (1991) 219-227
6. Bliss T.V.P., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
7. Bliss T.V.P., and Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol (Lond) 232 (1973) 331-356
8. Bush A.I. Metal complexing agents as therapies for Alzheimer's disease. Neurobiol Aging 23 (2002) 1031-1038
9. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci 26 (2003) 207-214
10. Bush A.I., and Masters C.L. Clioquinol's return: Cautions from Japan: Response. Science 292 (2001) 2251-2252
11. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y.S., Huang X.D., Goldstein L.E., Moir R.D., Lim J.T., Beyreuther K., Zheng H., Tanzi R.E., Masters C.L., and Bush A.I. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30 (2001) 665-676
12. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., and Ueland P.M. Folate, vitamin B-12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55 (1998) 1449-1455
13. Cory-Slechta D.A., Weiss B., and Cox C. Performance and exposure indices of rats exposed to low concentrations of lead. Toxicol Appl Pharmacol 78 (1985) 291-299
14. Cory-Slechta D.A. Exposure duration modifies the effects of low-level lead on fixed-interval performance. Neurotoxicology 11 (1990) 427-442
15. Gilbert M.E., Mack C.M., and Lasley S.M. Chronic developmental lead exposure increases the threshold for long-term potentiation in rat dentate gyrus in vivo. Brain Res 736 (1996) 118-124
16. Gilbert M.E., Mack C.M., and Lasley S.M. The influence of developmental period of lead exposure on long-term potentiation in the adult rat dentate gyrus in vivo. Neurotoxicology 20 (1999) 57-69
17. Gortz P., Hoinkes A., Fleischer W., Otto F., Schwahn B., Wendel U., and Siebler M. Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity. J Neurol Sci 218 (2004) 109-114
18. Hermeslima M., Pereira B., and Bechara E.J.H. Are free-radicals involved in lead-poisoning. Xenobiotica 21 (1991) 1085-1090
19. Huang X.D., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D.A., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., and Bush A.I. Cu (II) potentiation of Alzheimer A beta neurotoxicity: Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274 (1999) 37111-37116
20. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J.O., Boonplueang R., Viswanath V., Jacobs R., Yang L., Beal M.F., DiMonte D., Volitaskis I., Ellerby L., Cherny R.A., Bush A.I., and Andersen J.K. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease. Neuron 37 (2003) 899-909
21. Monteiro H.P., Abdalla D.S., Acruri A.S., and Bechara E.J. Oxygen toxicity related to exposure to lead. Clin Chem 31 (1985) 1673-1676
22. Moretti R., Torre P., Antonello R.M., Cattaruzza T., Cazzato G., and Bava A. Vitamin B12 and folate depletion in cognition: A review. Neurol India 52 (2004) 310-318
23. Mortensen M.E., and Walson P.D. Chelation-therapy for childhood lead-poisoning: the changing scene in the 1990s. Clin Pediatr 32 (1993) 284-291
24. Needleman H.L., and Gatsonis C.A. Low-level lead-exposure and the IQ of children: a meta-analysis of modern studies. JAMA 263 (1990) 673-678
25. Nguyen T., Hamby A., and Massa S.M. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc Natl Acad Sci U S A 102 (2005) 11840-11845
26. Padmanabhan G., Becue I., and Smith J.A. Clioquinol. In: Klauss E., and Florey F. (Eds). Analytical profiles of drug substances (1989), Academic Press, New York 57-90
27. Porru S., and Alessio L. The use of chelating agents in occupational lead poisoning. Occup Med Oxf 46 (1996) 41-48
28. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 5 (2006) 949-960
29. Rice D.C. Lead-induced changes in learning: evidence for behavioral mechanisms from experimental animal studies. Neurotoxicology 14 (1993) 167-178
30. Ritchie C.W., Bush A.I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R.E., and Masters C.L. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial. Arch Neurol 60 (2003) 1685-1691
31. Ruan D.Y., Chen J.T., Zhao C., Xu Y.Z., Wang M., and Zhao W.F. Impairment of long-term potentiation and paired-pulse facilitation rat hippocampal dentate gyrus following developmental lead exposure in vivo. Brain Res 806 (1998) 196-201
32. Sandhir R., Julka D., and Gill K.D. Lipoperoxidative damage on lead-exposure in rat-brain and its implications on membrane-bound enzymes. Pharmacol Toxicol 74 (1994) 66-71
33. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99 (1992) 195-231
34. Tabira T. Clioquinol's return: Cautions from Japan. Science 292 (2001) 2251
35. Tateishi J. Subacute myelo-optico-neuropathy: Clioquinol intoxication in humans and animals. Neuropathology 20 (2000) S20-S24
36. Wang H.X., Wahlin A., Basun H., Fastbom J., Winblad B., and Fratiglioni L. Vitamin B-12 and folate in relation to the development of Alzheimer's disease. Neurology 56 (2001) 1188-1194
37. White A.R., Du T., Laughton K.M., Volitakis I., Sharples R.A., Xilinas M.E., Hoke D.E., Holsinger R.M.D., Evin G., Cherny R.A., Hill A.F., Barnham K.J., Li Q.X., Bush A.I., and Masters C.L. Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281 (2006) 17670-17680
38. Yassin M.S., Ekblom J., Xilinas M., Gottfries C.G., and Oreland L. Changes in uptake of vitamin B-12 and trace metals in brains of mice treated with clioquinol. J Neurol Sci 173 (2000) 40-44
39. Zaiser A.E., and Miletic V. Prenatal and postnatal chronic exposure to low levels of inorganic lead attenuates long-term potentiation in the adult rat hippocampus in vivo. Neurosci Lett 239 (1997) 128-130